Related Experiment Video
Updated: Apr 21, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
11.7K
Ultra-low dose - new approaches in menopausal hormone therapy
P Stute1, H-G Becker, J Bitzer
1Department of Obstetrics and Gynecology, University of Berne.
Climacteric : the Journal of the International Menopause Society
|October 22, 2014
Summary
Ultra-low-dose menopausal hormone therapy (MHT) effectively manages vasomotor symptoms for many women. However, it may not sufficiently prevent bone fractures associated with estrogen deficiency.
Area of Science:
- Reproductive Endocrinology
- Gerontology
- Pharmacology
Background:
- Increasing life expectancy leads to a longer postmenopausal period, with women spending approximately one-third of their lives in an estrogen-deficient state.
- Effective management of acute menopausal symptoms and prevention of chronic estrogen deficiency sequelae are crucial.
- International guidelines recommend the lowest effective hormone dosage for menopausal hormone therapy (MHT) to relieve vasomotor symptoms.
Purpose of the Study:
- To review the advantages and disadvantages of ultra-low-dose MHT.
- To evaluate the efficacy of ultra-low-dose MHT in Swiss women after its initial years of use.
Main Methods:
- Expert review by eight national menopause specialists.
- Analysis of clinical data and guidelines regarding ultra-low-dose MHT.
Main Results:
- Ultra-low-dose MHT can effectively decrease vasomotor symptoms in many women.
- The data suggests that ultra-low-dose MHT may not be sufficient for guaranteeing fracture prevention.
Conclusions:
- Ultra-low-dose MHT offers a viable option for managing menopausal vasomotor symptoms.
- Further investigation is needed to confirm the long-term skeletal benefits of ultra-low-dose MHT.
Related Concept Videos
01:28Menopause
5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
01:22Hormonal Regulation of the Menstrual Cycle
2.3K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.3K
01:40Hormonal Regulation
37.3K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
37.3K
01:33Hormonal Regulation
29.9K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
29.9K
01:21Intrauterine Drug Delivery Systems
159
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
159
01:19Mitral Valve Prolapse III: Nursing Management
568
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
568